Myung In Pharmaceutical LTD.

Research Myung In Pharmaceutical LTD. (317450.KS) on Bullrun: market cap KRW 603.71B, dividend yield 4.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 603.71B; dividend yield is 4.8%.

Peer valuation comparison

Latest dividend yield is 4.84% versus a Healthcare sector median of 2.4% (101.7% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 603.71Bn/a4.8%2000

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2000 KRW, yield 4.8%.

About Myung In Pharmaceutical LTD.

Myung In Pharmaceutical LTD., a pharmaceutical company, manufactures ETC and OTC drugs. It offers products in the areas of thrombosis and anti-platelet, anti-hypertensive, anti-angina, anti-parkinson, anti-dementia, anti-epileptics, anti-schizophrenia, anti-depressants, adhd, anti-insomnia, gum disease treatment, gastrointestinal, cold-cough medicine, anti-fever, anti-pain, anti-inflammation agent, nutrition supplements and other pharmaceuticals.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Myung In Pharmaceutical LTD.'s market cap?

Myung In Pharmaceutical LTD.'s market capitalization is KRW 603.71B.

Does Myung In Pharmaceutical LTD. pay a dividend?

Myung In Pharmaceutical LTD. has a dividend yield of 4.8%.

What does Myung In Pharmaceutical LTD. do?

Myung In Pharmaceutical LTD., a pharmaceutical company, manufactures ETC and OTC drugs. It offers products in the areas of thrombosis and anti-platelet, anti-hypertensive, anti-angina, anti-parkinson, anti-dementia, anti-epileptics, anti-schizophrenia, anti-depressants, adhd, anti-insomnia, gum disease treatment, gastrointestinal, cold-cough medicine, anti-fever, anti-pain, anti-inflammation agent, nutrition supplements and other pharmaceuticals.